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Abstract: In the United States, there is a largely hidden
burden of diseases caused by a group of chronic and
debilitating parasitic, bacterial, and congenital infections
known as the neglected infections of poverty. Like their
neglected tropical disease counterparts in developing
countries, the neglected infections of poverty in the US
disproportionately affect impoverished and under-repre-
sented minority populations. The major neglected infec-
tions include the helminth infections, toxocariasis, stron-
gyloidiasis, ascariasis, and cysticercosis; the intestinal
protozoan infection trichomoniasis; some zoonotic bac-
terial infections, including leptospirosis; the vector-borne
infections Chagas disease, leishmaniasis, trench fever, and
dengue fever; and the congenital infections cytomegalo-
virus (CMV), toxoplasmosis, and syphilis. These diseases
occur predominantly in people of color living in the
Mississippi Delta and elsewhere in the American South, in
disadvantaged urban areas, and in the US–Mexico
borderlands, as well as in certain immigrant populations
and disadvantaged white populations living in Appala-
chia. Preliminary disease burden estimates of the neglect-
ed infections of poverty indicate that tens of thousands,
or in some cases, hundreds of thousands of poor
Americans harbor these chronic infections, which repre-
sent some of the greatest health disparities in the United
States. Specific policy recommendations include active
surveillance (including newborn screening) to ascertain
accurate population-based estimates of disease burden;
epidemiological studies to determine the extent of
autochthonous transmission of Chagas disease and other
infections; mass or targeted treatments; vector control;
and research and development for new control tools
including improved diagnostics and accelerated develop-
ment of a vaccine to prevent congenital CMV infection
and congenital toxoplasmosis.
Introduction
In the United States of America, the mortality rate resulting
from infectious diseases has declined precipitously over the course
of the twentieth century [1], and major scourges such as typhoid
fever and malaria are no longer serious public health threats [2].
However, among the poorest populations living in the US there
remains highly prevalent a group of serious parasitic and bacterial
diseases such as Chagas disease, cysticercosis, and toxocariasis [3],
which, like the neglected tropical diseases (NTDs), are character-
ized by their high prevalence, chronic and disabling features, and
disproportionate effect on the poor [3,4]. These infections occur
outside of tropical regions of Africa, Asia, and Latin America, and
I refer to them as neglected infections of poverty, because they not well
known to the US public-health community, and they promote
poverty because of their impact on child development, pregnancy
outcomes, and worker productivity [5]. In this review I highlight
the largely underappreciated burden of the neglected infections of
poverty in the US and make policy recommendations for
addressing such health disparities.
The Distressed Regions of Poverty in the United
States
Demographers and other social scientists measure poverty in a
number of ways [6,7], but since the 1960s, the US Census Bureau
has used a set of income thresholds that vary by family size and
composition [8,9]. In 2006, there were 36.5 million Americans
living in poverty, and the official US poverty rate was 12.3%
[9,10]. However, among under-represented minorities and
children, the poverty rate is much higher, particularly in single-
parent households headed by women (Table 1). Poverty in the US
is not evenly distributed, but instead it is focally concentrated into
several defined geographic regions, each with unique socioeco-
nomic characteristics. Glasmeier has identified six major distressed
regions of poverty: Appalachia, the Mississippi Delta, other areas
of rural poverty especially in the American South, Native
American tribal lands, the borderlands between the United States
and Mexico, and highly racially segregated urban areas including
mostly black metro areas adjacent to the Great Lakes and in the
Northeast [11]. Holt has conducted a spatial analysis of the
poverty in the United States at the county level and independently
identified similar areas of poverty (Figure 1) [12].
A robust dataset links poverty to both lower life expectancies
from chronic diseases (especially cancer and heart disease) and
increased infant and child mortality [13–16]. Partly on this basis,
and building on an analysis of mortality by race and ethnicity in
2,077 counties or county clusters, Murray et al. divided the US
population into eight groups with different epidemiologic patterns
and mortality rates [14]. Among these eight ‘‘Americas’’ were four
socioeconomically disadvantaged groups with substantially higher
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Table 1. Selected US Census Bureau 2006 Poverty Data.
Category Poverty Rate Reference
Official poverty rate 12.3% [9]
Non-Hispanic white 8.2% [9]
Non-Hispanic black 24.3% [9]
Hispanic 20.6% [9]
Children under age 18 y 17.4% [9]
Black female householder, no husband present, with children under age 18 y 43.6% [10]
Hispanic female householder, no husband present, with children under age 18 y 42.5% [10]
doi:10.1371/journal.pntd.0000256.t001
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whites living in Appalachia and the Mississippi Valley; America 5,
Native Americans living on reservations in the West; America 7,
poor blacks living in the rural South; and America 8, blacks living
in high-risk urban environments [14].
Using a hybrid of these classifications it is possible to identify
groups of individuals based on race, ethnicity, and socioeconomic
status that are at particular risk for specific neglected infections of
poverty. In this paper I review the prevalence of the major
neglected diseases of poverty in the US This analysis was
conducted in January 2008 using the online database PubMed
[17] for 1972–2007 with the Medical Subject Headings (MSHs)
‘‘neglected diseases’’, ‘‘poverty’’, the specific geographic regions
and racial, ethnic, and socioeconomic groups listed above
[11,12,14], and the specific diseases listed as NTDs on the PLoS
Neglected Tropical Diseases journal scope page [18], as well as major
congenital infections associated with impaired child development
including cytomegalovirus (CMV) infection, toxoplasmosis, and
syphilis. I also reviewed reference lists of identified articles and
hand-searched reviews. I report here either previously published
estimates of the number of cases of each neglected infection, or I
provide a range of estimates based on reported prevalence rates
among selected communities multiplied by published estimates of
the population at risk having similar socioeconomic, racial, and
ethnic demographics (Table 2). For some neglected infections,
particularly the soil-transmitted helminth infections, no new
surveys have been reported since the 1980s. Some of the regional
and national prevalence estimates were modified from a chapter in
my recently published book on neglected tropical diseases [19].
Appalachia
The hilly and mountainous region known as Appalachia
comprises parts of 13 states (Figure 1) [11]. Poverty and isolation
is particularly severe in Central Appalachia, which includes parts
of West Virginia, Eastern Kentucky and Tennessee, and the
southwestern tip of Virginia [11]. The plight of the poorest people
in this region, typically those working in the coal mining industry,
was brought to national attention both during the early 1960s
when John F. Kennedy made a presidential campaign swing
through the region [20] and with the 1962 publication of Michael
Harrington’s book, The Other America: Poverty in the United States [21].
In 2000, it was estimated that 169,000 housing units in
Appalachia, particularly Central Appalachia, had no indoor
plumbing [11]. Almost 3% of the region overall lacks complete
plumbing, although in some counties plumbing is incomplete in
upwards of 25% of the housing units [11].
Ascariasis. The parasitic worm infection ascariasis is one of
the world’s most common neglected tropical diseases [4], and a
leading global cause of impaired child development [22]. In very
young children, high-intensity Ascaris lumbricoides infections also
cause intestinal obstruction [22,23]. During the 1930s, the
profound poverty and inadequate sanitation in Appalachia was
linked to high rates of ascariasis [24]. For instance, it was noted
that among children aged 5–14 y, the prevalence in Breathitt
County in Eastern Kentucky was 75%, higher than in many
developing countries [24]. During the late 1970s Walzer et al.
reported that approximately 14% of schoolchildren in Clay
County (Eastern Kentucky) were infected with A. lumbricoides and
almost 13% were also infected with the whipworm Trichuris trichiura
[25], while other investigators also reported that ascariasis was still
highly endemic in the region [26–28]. Warren previously
estimated that four million people are infected with A.
lumbricoides in the US (Table 2) [29]: however, no surveys for
ascariasis have since been conducted.
Strongyloidiasis. Strongyloidiasis, caused by the
threadworm Strongyloides stercoralis, is another important soil-
transmitted helminth infection, associated with chronic enteritis,
impaired child development, eosinophilia, and hyperinfection in
immunocompromised hosts [30–32]. The disease is under-
reported partly because of the difficulty of diagnosing the
infection by fecal examination [32,33]. A review of several
studies conducted during the 1960s, 70s, and 80s and
determined that the prevalence in Central Appalachia ranged
from 0.4% (Charleston, West Virginia) to 4.0% (Harlan County,
Kentucky, and Johnson City, Tennessee) [32]. Based on 3,271
fecal examinations in Kentucky, Walzer et al. estimated that the
overall prevalence was approximately 1% [25]. A high percentage
of the patients with strongyloidiasis were found to be older white
males, most of whom had underlying chronic illnesses including
chronic obstructive pulmonary disease [25,30,32,34]. These
infections may have been acquired in coal mines. Murray et al.
determined that 11 million people compose the poor white
Appalachians in America 4 [14], while the Centers for Disease
Control and Prevention (CDC) reported that the population of
rural Appalachia is approximately 6.8 million [35]. Based on
Walzer’s prevalence determination of 1%, I estimate there are
approximately 68,000 [19] to 110,000 Appalachians infected with
S. stercoralis (Table 2).
Mississippi Delta and the American South
Throughout the twentieth century and continuing today, the
Mississippi Delta (‘‘the Delta,’’ composed predominantly of the
Delta regions of Mississippi, Louisiana, Arkansas, and Tennessee,
but also including the adjacent ‘‘boot-heel’’ of Missouri) and the
areas of the former Cotton Belt in the American South, have
remained among the poorest regions in the nation (Figure 1) [11].
High rural poverty rates, inadequate housing, and poor health are
the hallmarks of poverty in the Delta and adjacent regions [11,36].
More than one-half of the population is black [37], and over one-
third of the total Delta black population lives in poverty, as does
almost one-half of the rural black Delta population [11]. Overall,
5.8 million people live in America 7, the poor blacks of the rural
American South [14].
In the first half of the twentieth century as many as 42% of black
schoolchildren in the Delta had splenomegaly indicative of active
malaria infection, and almost twice as many blacks died from
malaria as whites [2]. The high rates of malaria among blacks
were attributed to exposure to Anopheles mosquitoes as a result of
crowding and inadequate housing located next to swampy land,
and diminished host resistance because of malnourishment and
overwork [2]. Throughout the American South during the early
twentieth century, malaria combined with hookworm infection
and pellagra to produce a generation of anemic, weak, and
unproductive children and adults [2,19,38,39]. By the 1960s these
infections were no longer endemic in the Delta, but the health
status (as measured by cancer and heart disease mortality rates and
infant mortality rates) of the eight states that make up the this
region still consistently ranks at the bottom among all the United
States [36]. Tuberculosis rates among southern blacks are also
considerably higher than whites [40–42]. Poverty is a major
determinant but not the only one [40], as incarceration and other
involuntary social forces also account for high rates of tuberculosis
and some sexually transmitted infections [40,42–44]. For the
blacks living in the Delta and elsewhere in the American South,
several parasitic and congenital infections rank among the most
important neglected infections of poverty, especially in post-
Katrina Louisiana.
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Louisiana. Despite the apparent eradication of malaria and
hookworm infection from the American South [2,19,38,45], other
important parasitic infections remain, particularly in Louisiana.
Even before Hurricane Katrina, the Delta region of Louisiana
exhibited some of the highest poverty rates in the nation—in 2000,
approximately 36% of blacks lived below the poverty level in this
area [11]. It was previously determined that, outside of Appalachia,
Louisiana exhibited some of the highest rates of ascariasis in the US
[24], and during the 1970s and 1980s considerable numbers of the
rural residents of Louisiana and elsewhere in the American South
were infected [23,46–50]. Some children exhibited parasite
intensities high enough to produce acute intestinal obstruction
[23,28]. Although A. lumbricoides infections were highest in rural
Louisiana, they were also prevalent among kindergarten children
living in New Orleans [51]. In addition, during the 1970s and 1980s
Louisiana children were at risk for infection with the dog
roundworm, Toxocara canis [52], and up to 30% of rural black
children, mostly in the South, were seropositive for this infection
(toxocariasis will be discussed in the section on inner cities) [53].
Unfortunately, no surveys for either ascariasis or toxocariasis in
Louisiana have been published since the 1980s.
Following the devastation of Hurricane Katrina in 2005,
prolonged flooding combined with poverty to create conditions
that could promote the emergence of additional neglected
infections, including vector-borne viral diseases such as dengue
fever [54–56] and Chagas disease [57,58]. Chagas disease is of
particular concern, because of the noted rise in domestic
triatomines, especially Triatoma sanguisuga, which transmits the
causative American trypanosome Trypanosoma cruzi [57,58]. In
Louisiana, almost 30% of the armadillos and 38% of the opossums
are infected with T. cruzi, and a case of Chagas disease was
recently reported in post-Katrina New Orleans [57]. Therefore,
many of the requirements for autochthonous Chagas disease
transmission are in place in Louisiana [58], with an established
case already present. In the coming decade, global warming and
increased flooding in the region could combine to promote dengue
and Chagas disease epidemics among the poor in Louisiana [55].
The feminization of poverty. The term ‘‘feminization of
poverty’’ refers to the observation that in the US and elsewhere
women often have fewer economic resources than do men and are
more likely to be heads of single-parent families [59]. Poverty is
particularly feminized among black women [59]. As shown in
Table 1, almost one-half of black female heads of single-parent
households live below the poverty level, and black mothers are
twice as likely to have premature or low birth weight infants or to
have infants that die in infancy than white mothers [16].
Congenital infections, typically the result of primary
Table 2. Estimated Prevalence of Neglected Infections of Poverty in the US.
Neglected Disease Category Disease Estimated Number of Cases Major Regions or Populations at Risk References
Soil-transmitted helminth
infections
Ascariasis ,4 million Appalachia, American South [29]
Toxocariasis 1.3–2.8 million Inner cities, American South, Appalachia [14,79,84]
Strongyloidiasis 68,000–100,000 Appalachia, African refugees [14,19,25,35]
Trichinellosis 16 (insufficient data) Arctic Alaska [149]
Platyhelminth Infections Cysticercosis 41,400–169,000 US–Mexico borderlands [19,96,113]
Schistosomiasis 8,000 African refugees [89,90]
Echinococcosis Insufficient data Tribal Lands and Arctic Alaska —
Protozoan Infections Giardiasis 2.0–2.5 million All regions [123,147]
Trichomoniasis 880,000 (black women) American South, inner cities [14,66]
Cryptosporidiosis 300,000 All regions [123]
Chagas disease 3,000 to .1 million US–Mexico borderlands, American South [11,102,103,105,109]
Cyclosporiasis 16,624 All regions [123]
Congenital toxoplasmosis #4,000 annually American South, inner cities, US–Mexico
borderlands, Arctic Alaska
[65]
Leishmaniasis Insufficient data US–Mexico borderlands —
Amebiasis Insufficient data US–Mexico borderlands —
Bacterial Infections Congenital syphilis 1,528 between 2000 and 2002 American South, inner cities [62]
Brucellosis 1,554 US–Mexico borderlands [122,123]
Bovine tuberculosis 129 cases between 1994 and 2000 US–Mexico borderlands [124]
Leprosy 166 US–Mexico borderlands [148]
Trench fever Insufficient data Inner cities —
Leptospirosis Insufficient data Inner cities —
Viral Infections Dengue fever 110,000–200,000 new infections
annually
US–Mexico borderlands, American South [11,95,96]
Congenital CMV 27,002 annually; 6,652 in
blacks; 4,196 in Hispanics
American South, inner cities [64]
Human rabies 2 All regions [149]
doi:10.1371/journal.pntd.0000256.t002
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during pregnancy, are important factors underlying these high
rates of poor birth outcome. These congenital infections cause
devastating long-term neurological dysfunction including cognitive
impairments, intellectual retardation, and hearing and vision loss
[60–62]. In this way, the major congenital infections are also
important poverty-promoting factors causing billions of dollars in
economic losses [60]. In the US, black children and their mothers
bear a disproportionate congenital disease burden [63]. With
respect to congenital CMV, black women exhibit a 4-fold increase
in primary infection during pregnancy compared to white women,
and when stratified for women between the ages of 12 and 19
there is almost a 50-fold increase [64]. Of the estimated 27,002
primary CMV infections in pregnancy in the US estimated to
occur annually, 6,652 of them occur in black women (Table 2)
[64]. Similarly, almost 55% of the cases of congenital syphilis
occur among blacks [62], and blacks suffer from higher rates of
toxoplasmosis than do whites (Table 2) [65]. In addition to
primary infections during pregnancy and congenital infections,
black women also exhibit an approximately 10-fold higher
prevalence of trichomoniasis (13.3%) than white (1.3%) women
[66]. Based on Murray’s estimate that 13.3 million blacks live
either in America 7 (rural South) and in America 8 (high-risk
urban environments [14]), I estimate that approximately 880,000
black women in the US are infected with the protozoan parasite
Trichomonas vaginalis (Table 2).
Disadvantaged Urban Enclaves (Inner Cities)
High-poverty areas in American inner cities are sometimes
defined as neighborhoods where more than 40% of the population
is poor [67]. Jargowsky described such neighborhoods as ones that
‘‘tend to have a threatening appearance marked by dilapidated
housing, vacant units with broken or boarded up windows,
abandoned or burned out cars, and men ‘hanging out’ on street
corners’’ [67]. One measure of inner city poverty used by
sociologists and economists is a dissimilarity index, which measures
the degree of segregation by race and income, with blacks living in
the poorest neighborhoods [11]. The cities with the highest
dissimilarity index are the Northeastern cities and the Midwestern
cities near the Great Lakes (Figure 1) [11]. Several neglected
infections are present in these and other disadvantaged urban
enclaves.
Rat-borne and louse-borne bacterial infections. Over the
last two decades, outbreaks of leptospirosis, a bacterial infection
transmitted through rat urine and responsible for a serious
hemorrhagic complication known as Weil’s disease, have been
reported among the poor living in Baltimore [68] and Detroit
[69,70]. Similarly, bartonellosis, caused by the gram-negative
bacterium Bartonella quintana, has emerged among the homeless
[71–73]. B. quintana is the cause of louse-borne trench fever, so
named because it was common among soldiers living under
extreme conditions in the trenches during World War I [71,72].
Beginning in the 1990s, small outbreaks of B. quintana bacteremia
and endocarditis was noted among the homeless living in Seattle,
Washington, and elsewhere [71–73]. With global warming and
increased flooding such rat- and louse-borne infections may
increase among the homeless [55].
Toxocariasis. Toxocariasis is an important neglected
infection of poverty among socioeconomically disadvantaged
black children [53,74,75]. Playgrounds and sandboxes in poor
urban neighborhoods are often contaminated with eggs of the dog
roundworm, Toxocara canis [75,76]. When children accidentally
ingest these roundworms eggs the released larvae migrate through
tissues to cause visceral larval migrans and eosinophilic granuloma
of the liver [74,75,77] or ocular larva migrans [74,78]. Another
form of the disease, covert toxocariasis, has been associated with
asthma [75,79,80], and may possibly be linked to the rise in asthma
observed in inner city children [81], as well as impaired cognitive
development and lower intelligence [75,82,83]. Based on serologic
studies that measure antibody to T. canis antigens, the prevalence
rate of toxocariasis among inner city blacks living in Connecticut
cities was found to be 10% and even higher among inner city
Hispanics [79]. As noted previously, the prevalence among
socioeconomically disadvantaged blacks in the American South
was as high as 30% [53]. In an unpublished study from the CDC it
was recently estimated that approximately 21% of blacks are
seropositive ([84] and Peter Schantz, personal communication),
indicating exposure to the parasite. I previously estimated that
approximately 500,000 blacks are seropositive for T. canis antibody
[19]. However, based on the estimate that 13.3 million
impoverished blacks live in America 7 and 8 [14] and prevalence
estimates between 10% and 21%, as many as 1.3 million to 2.8
million individuals may be exposed or infected (Table 2).
African Refugees and Other Special Immigrant Groups
Since the 1980s, the US has relocated and successfully treated
populations of refugees from Southeast Asia and other developing
regions with high prevalence rates of helminth infections—
especially hookworm infection, filarial infections, and strongyloi-
diasis [85–87]—tuberculosis, and hepatitis B [88]. Beginning in
2000, the immigration of refugees from sub-Saharan Africa
markedly increased [89], and today the US settles an estimated
70,000 refugees annually, including 25,000 refugees from Africa
[90]. Notable among the refugees are the ‘‘Lost Boys and Girls of
Sudan,’’ raised initially in poor Ethiopian refugee camps before
relocating to Kenya [89]. Since 2000, almost 4,000 Lost Boys and
Girls have been settled in the US. By serologic testing it was
determined that almost one-half of these special immigrants are
seropositive for both schistosomiasis (mostly Schistosoma mansoni
infection) and strongyloidiasis [90]. In addition, an estimated
8,000 Somali Bantu have been relocated to the US, with up to
three-fourths of them seropositive for schistosomiasis (most likely
Schistosoma haematobium infection) and one-fourth positive for
strongyloidiasis [90]. It is generally accepted that seropositivity
for these two parasitic infections is a result of chronic and
persistent untreated infections [89]. Therefore, of the roughly
4,000 Sudanese immigrants and 8,000 Somali immigrants there
are approximately 8,000 cases of schistosomiasis and 3,000 cases
of strongyloidiasis (Table 2). Accordingly, the CDC now
recommends presumptive treatment for these special immigrant
populations with anthelminthics [89–91].
The Borderlands of Mexico
An estimated 10 million people live in the border region
between the US and Mexico, many of whom are of Hispanic
heritage (the majority American citizens) (Figure 1) [11]. These
border communities are among the poorest in the US, and
substandard or inadequate housing is common to the region [11].
Several important neglected infections of poverty occur in this
setting, including vector-borne diseases, helminth infections, and
other zoonoses. A related at-risk population is the estimated
750,000 to 12 million migrant farm laborers from Mexico and
Central America [92].
Vector-borne diseases: Dengue, Chagas disease, and
leishmaniasis. Poor housing without plumbing, air
conditioning, or window screens is a key factor in promoting
vector-borne diseases [93]. It has been estimated that this situation
describes more than 30,000 border households, in addition to
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period between 1980 and 1999 there were 65,514 cases of dengue
fever reported from the Mexico side of the border, compared to
only 64 cases in the US [55,94,95]. An earlier assessment
suggested that the higher-quality dwellings on the US side
accounted for this disparity [55]; however, more recent studies
indicate that dengue is under-reported in the US near the Mexican
border [95]. A cross-sectional survey in Brownsville, Texas and
Matamoros Tamaulipas, Mexico detected 2% and 7.3% recent
infections, respectively, with evidence of past infection in 40% of
Brownsville residents [95]. Risk factors and predictors of dengue
among the Brownsville residents include low weekly family
income, absence of air conditioning, and inadequate street
drainage [95]. Assuming that 10 million people live in the US–
Mexico borderlands, a 2% prevalence of recent infections [95]
translates to approximately 200,000 people with recent dengue
fever (Table 2). Alternatively, the Pew Hispanic Center estimates
that there are 26,784,268 Mexican Americans living in the US
[96]. At an overall poverty rate of 20.6% for Hispanics in the US
(Table 1), there are almost six million impoverished Mexican
Americans in the US. If 2% of this population suffers from a recent
dengue infection, I estimate there are 110,000 recent dengue
infections in the US (Table 2).
In addition to evidence for Chagas disease in post-Katrina
Louisiana as described above, the US borderlands with Mexico
have also emerged as an endemic region [97–109]. Because of
concerns about the risk of new contamination of the national blood
supply with T. cruzi [98,100,101,103], with a recent estimate that
between 1 in 4,655 and 1 in 25,000 US blood donors are
seropositiveforT.cruziantibodiesand presumed infected [100,109],
there is great interest in expanding current blood screening efforts
[98]. In 2006, the US Food and Drug Administration approved a
new commercial ELISA test for blood donation screening that
utilizes parasite lysate antigens for detection of antibodies [98,100].
Estimates of the prevalence of Chagas disease along the Mexico
border and in the US vary widely. Previously, it was estimated that
50,000 to 100,000 Latin American immigrants in the US are
infected [103], but more recently it was found that of 10,192 blood
specimens from El Paso, Texas, of which 73% were from donors of
Hispanic origin, three donors were positive [109]. With an overall
prevalence of 0.03% [109] and 10 million people living in the US–
Mexico borderlands [11], I estimate that approximately 3,000
people have Chagas disease in the region. Other estimates are
considerably higher. Milei et al. argued that there are 370,000 T.
cruzi–infected individuals in the US during the 1990s [105], while
Hanford et al. revised these estimates to suggest that over one
million Hispanics in the US have Chagas disease (with almost
270,000 in Texas alone) and that at least 150,000 Latin America–
born immigrants are expected to develop clinically apparent
chronic Chagas disease [102]. Congenital Chagas disease may also
occur [98,110]. Of particular concern is the possibility that T. cruzi
transmission to humans today occurs in the US–Mexico border-
lands. In South Texas and elsewhere along the US–Mexico
borderlands, dogs and coyotes are seropositive and there is a
domestic canine transmission cycle [97]. In addition, wood rats are
common hosts, and the infection occurs among domestic cattle,
horses, and sheep [102]. Infected vectors or hosts are present in 64
of the 254 counties in Texas [102], so people living in the estimated
30,000 poor-quality dwellings in the borderlands region are at high
risk for transmission.
Another vector-borne neglected disease, cutaneous leishmania-
sis, is transmitted by sandflies and is endemic in Mexico and
Central America. Infection with Leishmania mexicana has been
reported from South Texas, including among individuals with no
travel history [111,112]; wood rats or other rodents may also serve
as reservoir hosts.
Cysticercosis and other zoonoses. Cysticercosis results
when humans accidentally ingest eggs of the pork tapeworm,
Taenia solium, which are shed or excreted by close household or
family contacts. This condition is now a leading cause of epilepsy,
seizures, and other neurological sequelae in the US–Mexico
borderlands [113–120], accounting for approximately 10% of
seizures presenting to emergency rooms in Los Angeles and,
presumably, other border cities as well [116]. With an incidence
rate of 8 to 10 per 100,000 per year among Hispanic populations
[117,119], I previously estimated that up to 3,500 new cases of
cysticercosis occur annually [19]. In a seroprevalence study of
rural Ventura County, California, it was found that 1.8% of that
population have cysticercosis [113,114]. I previously reported that
there are 41,400 Hispanics in the US with cysticercosis [19], but
based on the observation that 9.4 million Hispanics live in poverty
in the US [96], the number of people with cysticercosis may be
substantially higher. If 1.8% of this population is also infected,
there may be as many as 169,000 cases of cysticercosis among
Hispanics in the US (Table 2).
There are two other zoonoses of medical importance in the US–
Mexico borderlands. Brucellosis is one of the most common
zoonosis worldwide and a leading cause of disability [121]. Goat
and cow dairy products are an important source of infection from
Mexico [122], with 1,056 cases of brucellosis reported between
1993 and 2002 (although Mead et al. estimated that 1,554 cases
occur annually [123]), of which almost 80% of the cases occur
among individuals of Hispanic origin [122]. Between 1994 and
2000, 129 cases of bovine tuberculosis (Mycobacterium bovis) were
reported, nearly all among patients of Hispanic origin, particularly
children [124].
Neglected infections among migrant farm workers.
Approximately 95% of the several million migrant agricultural
workers in the US were born in Mexico, and almost all of them
live below the poverty line [92]. They have significant health
disparities, with case fatality rates more than five times the US
average. In addition to very high rates of HIV, tuberculosis, and
chronic diseases [92,125–127], the Mexican-born migrant workers
living in the US often suffer from high rates of parasitic infection,
including ascariasis and hookworm infection [92,128–130] (for
which there is evidence of autochthonous transmission on US
farms [131]), cysticercosis and Chagas disease [127,131], and
other neglected infections [92,125].
Tribal Lands and Arctic Native Americans
Approximately 4 million Native Americans are distributed
among 500 tribes in the United States, with approximately one-
fourth living on tribal lands or lands specifically designated as
Native American lands (Figure 1) [11]. Almost 30% of those living
on tribal lands live in poverty, where the child poverty rates are
more than 40% [11].
Neglected infections in continental US tribal lands. Across
the US, Native Americans are highly susceptible to diabetes mellitus
and obesity, and almost one-third of Native Americans die before the
age of 45 [11]. Up to 40% of Native Americans also live in
overcrowded conditions [11], and because of this and for additional
reasons of genetic susceptibility and low vaccine coverage, high rates
of invasive bacterial and viral respiratory infections occur among
Native Americans, especially the Navajo and Apache [132–135]. On
some reservations up to one in five homes lack complete in-house
plumbing, a rate that is 20 times the national average [11]. In this
setting, certain neglected infections of poverty are common. Over the
last twenty years in the American Southwest, trachoma has been
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has been endemic among the Navajo, Zuni, and Santo Domingo
Indians because of an enzootic dog–sheep cycle on tribal lands and
elsewhere in the region [138–140].
Neglected infections among the Inuit. Because of their
dietary reliance on meat from sea mammals and polar bear the
Inuit living in Alaska and the Canadian Arctic are at risk of food-
borne parasitic diseases, including echinococcosis, toxoplasmosis
and congenital toxoplasmosis, and trichinellosis [19]. Cystic
echinococcosis in the Arctic is due to an enzootic cycle involving
moose, reindeer, and elk [141], while trichinellosis caused by
Trichinella spiralis nativa is prevalent because of high rates of
infection among walruses and polar bear [142]. Toxoplasmosis
and congenital toxoplasmosis are also extremely common among
the Inuit, and are due to consumption of infected seal and caribou
meat [143].
Other Regions
The most diagnosed parasitic in the infection in the US is
giardiasis [144,145], with as many as 2.0–2.5 million cases
occurring annually [123,146]. The greatest number of cases
occurs between June and October and among children aged 1–4
and 5–9 y and adults aged 35–39 y [144]. An estimated 300,000
cases of cryptosporidiosis also occur annually [123], and this
infection has emerged as a leading cause of recreational water
outbreaks of diarrhea in the US and among patients with HIV/
AIDS [147]. A 10-fold increase in cryptosporidiosis transmission
occurs during the summer and early fall [147]. Although both
giardiasis and cryptosporidiosis are common, there is no evidence
to suggest that they disproportionately affect poor and under-
represented minority populations. In contrast, the intestinal
protozoan disease amebiasis does disproportionately affect the
poor, but no US prevalence data are available for this disease.
Among the notifiable neglected infections of poverty there were
166 cases of leprosy (with most of the cases in Texas, California,
New York and Louisiana [148]), 16 cases of trichinellosis, and two
cases of human rabies reported in 2005 (Table 2) [149].
Policy Recommendations
Based on my estimates of prevalence (Table 2) and other health
and socioeconomic impacts, the most important neglected
helminth infections of poverty in the US are the helminth diseases
toxocariasis (inner cities and the American South), ascariasis
(Appalachia and the American South), strongyloidiasis (Appala-
chia), and cysticercosis (US–Mexico borderlands). Among the
important vector-borne neglected infections are dengue and
Chagas disease in the US–Mexico borderlands and in post-
Katrina Louisiana. Congenital infections such as congenital CMV
and congenital syphilis stand out as health disparities in inner cities
and the American South. Trench fever and leptospirosis are
important among the homeless and other disadvantaged urban
populations.
Among the common features of these neglected infections are
(1) their highly disproportionate health impact on people of color
and people living in poverty; (2) their chronic, largely insidious,
and disabling features; and (3) their ability to promote poverty
because of their impact on child development, pregnancy
outcome, and productive capacity. It is important to note that,
while some of these neglected infections occur exclusively among
recent immigrant populations, most do not. Instead, poverty is the
single most important determinant. Control of these neglected
infections needs to be prioritized by policy makers and public-
health experts because it is both a highly cost-effective mechanism
for lifting disadvantaged populations out of poverty and consistent
with our shared American values of equity and equality [150]. The
World Health Organization also recognizes that control of
neglected diseases represents a fundamental human right [151].
An important obstacle to the control or elimination of the
neglected infections of poverty in the US is the absence of reliable
population-based estimates of prevalence and disease burden data
about these conditions [3,19]. These neglected infections are
underdiagnosed and most are not reportable to the CDC. The
estimates I provide here are preliminary and based on very few
active surveillance studies, including some obtained by analyses of
sera collected from National Health and Examination Surveys.
For some of the neglected infections of poverty, seropositivity may
be equated with active infection [89,90,95,109,113], whereas for
others it may reflect both current and past infections [53,74]. For
infections such as Chagas disease estimates reported here vary
widely. We also lack a system for the national collection of fecal
samples for intestinal parasitic infections. Expanded measures are
urgently needed to implement active surveillance and obtain
population-based estimates of the neglected infections (Table 3).
An added measure would be to expand newborn screening for
toxoplasmosis [3,152], and possibly congenital Chagas disease.
Screening for congenital toxoplamosis would also likely benefit
persons of all socioeconomic circumstances [61]. Such efforts
would create opportunities to determine the extent and true
disease burden of these neglected infections.
There is also an urgent need to better define the transmission
dynamics of some of the neglected diseases (Table 3). For Chagas
disease, and to some extent, dengue and leishmaniasis, the full
extent of authochthonous transmission in Louisiana and the US–
Mexico borderlands is poorly understood. A full appreciation of
Chagas disease transmission mechanisms would include molecular
genotyping of the parasite to determine whether different strains
or demes are endemic, and a complete characterization of the
different vectors and animal reservoir hosts. Similarly, the extent
of autochthonous cysticercosis transmission in the US is largely
unstudied, as it is for many of the bacterial zoonoses including
urban foci of leptospirosis and trench fever. For toxocariasis, the
contribution of feral versus domesticated animal reservoirs to
transmission is also not well understood.
Following enhanced surveillance and improved understanding
of transmission dynamics, there are several opportunities to treat
or prevent neglected infections of poverty in the US using existing
drugs or other control tools (Table 3). Through either population-
based drug administration or case identification and treatment, the
soil-transmitted helminths could be controlled by administration of
albendazole and ivermectin [22], while expanded use of
praziquantel would treat schistosomiasis among selected immi-
grant populations [90] and prevent transmission of T. solium eggs
and possibly reduce the incidence of cysticercosis [153]. Metro-
nidazole and tinidazole are available for the treatment of
trichomoniasis and giardiasis [154,155], and nitazoxanide is
available for cryptosporidiosis and giardiasis [144,156]. Pyrimeth-
amine plus sulfadiazine is used for the treatment of toxoplasmosis,
and the optimal length of treatment and its impact on child
development and neurological sequelae need to be determined
[61]. Antibiotics are available for the treatment of leptospirosis and
other bacterial zoonoses [157]. An important role also exists for
veterinary public health interventions to prevent zoonotic
transmission to humans, possibly including the mass treatment of
Toxocara-infected dogs, Toxoplasma-infected cats, and other mea-
sures [158]. The control of almost all of the neglected infections of
poverty would also benefit from improvements in environmental
sanitation, piped clean water, and improvements in housing in
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and leishmaniasis, consideration of expanded vector control
approaches is warranted [55,159].
Development of new control and prevention tools is needed
(Table 3). Currently, the serologic-based diagnostic tests for most
of the parasitic infections rely on extracts or crude preparations of
parasite antigens and would benefit from the development of
improved and widely available diagnostic kits that utilize
standardized and purified recombinant antigens. For Chagas
disease there is a particularly urgent need for rapid diagnostic tests
and polymerase chain reaction-based assays for detection of acute
and congenital infections. Furthermore, no drugs adequately and
reliably treat Chagas disease [160], dengue [161], or congenital
CMV infection [162]. Although vaccines for dengue [163] and
CMV infection [164] are under development, progress has been
slow because of inadequate resources and commercial incentives
[5]. A pediatric dengue vaccine initiative was recently established
through support by the Gates Foundation [163]. For CMV
infection, both a live attenuated vaccine and a recombinant
vaccine have been developed [164], but clinical testing in pregnant
women to determine the impact of these vaccines on vertical
transmission has been severely lagging because of inadequate
support—a tragedy, given that more than 10,000 congenital CMV
infections occur among infants of color annually [64].
In 2006, the annual budget of the National Institute of Allergy
and Infectious Diseases (NIAID) was $4.4 billion, with approxi-
mately $1.6 billion of this amount spent on biodefense [165]. Of
the selected disease-specific areas targeted for funding by the
NIAID in their published annual report, none specifically
mentions a neglected infection of poverty [165]. A consequence
of this lack of targeted funding for neglected diseases is that the
development of critically needed new tools for these conditions has
lagged behind those for biodefense. The Global Forum on Health
Research has coined the term ‘‘the 10/90 gap’’ to describe how
only 10% of resources are devoted to 90% of the global burden of
disease, i.e., that represented by disease disproportionately
occurring in developing countries [166]. The absence of
development of new tools for neglected infections of poverty, such
as those outlined above, highlights a unique American 10/90 gap
for poor people and people of color in the US.
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